Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Please provide 3-5 proposed reviewers (name, affiliation, email)
  • Please provide source data (raw data) such as data at Ms Excell, uncropped Western Blot or gel, and qPCR data
  • Please provide your phone number.

Author Guidelines


All accepted articles must conform to the following order:

  • Title (article title, full authorship, and affiliations, corresponding author contact details)
  • Abstract
  • Keywords (4–6)
  • Introduction
  • Methods
  • Results
  • Discussion
  • Conclusion (optional)
  • Acknowledgments
  • Declaration of Interests
  • Author contributors
  • References
  • Figure and tables

Title page. Titles should be informative but not excessively detailed or heavy on jargon. Please avoid abbreviations in the title. Please either define functionally (eg, “the influenza viral HA protein”) or spell out (“influenza viral hemagglutinin”). A brief title, author name(s), affiliation(s), and full address(es) (including street name, city, province, postal code, and country) of the authors must be included. Full names for all authors must be included in the format Anggun Cipta Sasmi, not Sasmi A.C. or A.C. Sasmi. The name and address of the corresponding author should be separately and clearly indicated with email address.

Abstract. Include an abstract in a single paragraph that contains background, methods, results, conclusion, not exceeding 250 words. 

Keywords. Please provide 4-6 keywords arranged alphabetically.

Introduction. Please include a clear explanation for the rationale of the study and sufficient scientific background information. The general reader (i.e., non-specialist) should have a clear sense of why the study was undertaken, and how the current study advances translational goals relative to the published literature. Define all abbreviations the first time even if they have been defined in the Abstract.

Methods. Provide sufficient detail to allow the work to be reproduced by an independent researcher. Methods that are already published should be summarized and indicated by a reference. Any modifications to existing methods should also be described.

Results. Subheadings should be fewer than 100 characters including spaces. Please describe the experiments clearly and what each figure shows. All figures and tables must be called out in sequential order. Tables should be provided in an editable Word or Excel format (so individual numbers/texts can be copied). Please ensure that each table fits within one A4-sized page.

Discussion. Please include a discussion on limitations, generalisability, and interpretation of results. The Discussion should be no longer than 5 pages of A4 paper. Please do not include subheadings in the Discussion, and please do not repeat a description of the results, and do not discuss Method in this part. Please conclude with a brief paragraph highlighting the main points of the study, including a statement regarding the translational value of the work. As with the Introduction and Abstract, please make sure the language is clear to the general audience, including non-specialists.

Acknowledgments. The acknowledgment should be filled with other contributors who are not qualified in the author's list. Research grant that supported the study should be listed in this section as well.

Declaration of interest. At the end of the text, under the subheading “Declaration of interests”, all authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted. If there are no conflicts of interest, authors should state that none exist

Author contributions. Please list here the contribution each author made to the manuscript—eg, literature search, figures, study design, data collection, data analysis, data interpretation, writing, etc. Please use CRediT taxonomy here. If all authors contributed equally, please state this. 

References. All references must be in Public Library of Science (PLOS) format or Vancouver-style formatting. Please see more detailed information below in the Formatting section.

Figure and Tables. Please provide titles for all figures. Captions should briefly describe the experiment and clearly describe the display item. There should be no discussion or statement (conclusion) about the results. Each part of the display item should be clearly defined and explained, e.g., numbers in the quadrant indicate the percentage of cells. Statistical tests should be clear. Error bars should be defined. The number of independent experiments must be indicated. Please be sure to include the number of subjects used for each experiment.


At Pharmacy Reports, it is our aim to curate concise and informative reviews of topical interest to researchers from both basic science and clinical realms. Reviews should be focused on a specific pharmacy topic. Reviews for Pharmacy Reports should provide a clear and logical synthesis of the literature on a potentially complex topic so that it can be easily understood by the general readership of the journal regardless of their expertise. Please avoid jargon, but do not oversimplify: be accurate and precise throughout. A good Review also provides a fresh point of view or a new conceptual framework on recent literature and proposes future directions in the field of study. Authors are encouraged to give their subjective opinion of the topics discussed, yet it is important that a fair and balanced representation of alternative viewpoints is presented. Although Reviews do allow room for some speculation and debate, it should be made clear where the authors’ own opinions are being presented.

Title. The title of the Review should be short and enticing (<10 words).

Authorship. We prefer the Review to have no more than 5 authors. Full names for all authors must be included in the format Anggun Cipta Sasmi, not Sasmi A.C. or A.C. Sasmi.

Abstract. With a maximum of 200 words, briefly explain the necessary background, and encapsulate the take-home message for a non-specialist reader. Please emphasize the recent developments or novel conclusions, concepts, or models that make your Review timely.

Keywords. Please provide 4-6 descriptive keywords.

Main text. Because we place an emphasis on concise and timely Reviews, the main text of the Review should be no more than 2000-4000 words (excluding references and tables). Please provide a synthesis, not a summary, of recent developments. Use concise, informative subheadings and provide clear links between sections.


  • This section contains Perspectives that accompany papers published in Pharmacy Reports or other journals, or to issues of wide-reaching concern in pharmacy. Most Perspectives are commissioned, but unsolicited Perspectives are also welcome. Perspectives may be peer-reviewed
  • Perspectives should be no more than 750 words, 10 references, and one figure, panel, or small table


  • Letters should be written in response to previous content published in Pharmacy Reports
  • Letters for publication must reach us within 4 weeks of the publication of the original item and should be no longer than 250 words and 5 references
  • Letters of general interest, unlinked to items published in the journal, can be up to 400 words long
  • Letters are not usually peer-reviewed, but we might invite replies from the authors of the original publication, or pass on letters to these authors
  • Only one table or figure is permitted, and there should be no more than 5 references and five authors
  • All accepted letters are edited. Proofs will be sent out to authors before publication


  • Any substantial error in any articles published in Pharmacy Reports should be corrected as soon as possible. Blame is not apportioned; the important thing is to set the record straight
  • The journals have a policy for types of errors that we do and do not correct. We will always correct any error affecting a nonproprietary drug name, dose, or unit, any numerical error in the results, or any factual error in the interpretation of results
  • Other corrections are at the Editor’s discretion




  • Manuscripts should be submitted in American English. Authors writing in Bahasa Indonesia is also allowed but will be assisted for English translation if the article is accepted. 

Formatting of text

  • Type a single space at the end of each sentence
  • Do not use boldface for emphasis within text
  • We use a comma before the final “and” or “or” in a list of items
  • Type decimal points midline (ie, 12.3, not 12,3)
  • Numbers one to ten are written out in words unless they are used as a unit of measurement, except in figures and tables
  • Use single hard-returns to separate paragraphs. Do not use tabs or indents to start a paragraph
  • Do not use the automated features of your software, such as hyphenation, endnotes, headers, or footers (especially for references). Please use page numbering


  • Cite references in the text sequentially in the PLoS or PLoS One numbering style.
  • Two references are cited separated by a comma, with no space.
  • If there are six authors or fewer, give all six in the form: surname space initials comma
  • If there are seven or more give the first three, in the same way, followed by et al
  • For a book, give any editors and the publisher, the city of publication, and year of publication
  • For a chapter or section of a book, also give the authors and title of the section, and the page numbers
  • For online material, please cite the URL, together with the date you accessed the website
  • Online journal articles can be cited using the DOI number
  • Do not put references in the Abstract and Conclusion
  • Example: 1. Pavlova  NN,  Thompson  CB.  The  emerging hallmarks  of cancer metabolism.  Cell Metab. 2016;23: 27-47. doi:10.1016/j.cmet.2015.12.00


  • All images must have a minimum resolution of 300 dpi, width 107 mm
  • The main figure heading should be in 10 points Arial font BOLD
  • Captions should be in 10 points, single-spaced
  • Be consistent with the font size throughout.
  • Use lowercase font (a, b, c…) to denote individual panels in a composite figure.
  • Do not add box outline to graphs.
  • Do not use titles in the graph or artwork. Titles should appear at the beginning of the figure legend.
  • Nomenclature and abbreviations should be consistent with the text.
  • All figure panels must be on a single page. (One figure per page, please.)


  • The main table heading should be in 10 points font BOLD
  • Legends should be in 10 points, single-spaced
  • Tables should be in 8 points font, single-spaced
  • Headings within tables should be in 8 points BOLD


  • SI units are required
  • Numbers in text and tables should always be provided if % is shown
  • Means should be accompanied by SDs, and medians by IQR
  • p values should be given to two significant figures, unless p<0.0001

Drug names

  • Recommended international non-proprietary name (rINN) is required
  • We encourage the use of neuroscience-based nomenclature for psychotropic drugs

Audio/video material

  • The paper to which the audio or video clip relates should be mentioned in the recording
  • Audio clip and video files should be accompanied with brief text explaining the content of the audio, names of interviewers/interviewees, date of recording, and place of recording if relevant
  • Written consent from all parties must be supplied at submission


  • Audio material submitted as an mp3 file, no larger than 50 Mb
  • Your paper may be selected for a podcast. If so, the Web Editor will contact you to arrange a pre-recorded interview to discuss your paper. 


  • Video material should be submitted in .mp4 format with an aspect ratio of 16:9, and be no larger than 50 Mb
  • We welcome your videos and invite you to submit any video material (reports, interviews, scans, imaging) for consideration in the online journal. Please ensure that all those featured in the video have given permission for publication (see also the previous section on Patient and other consents)
  • All video files can be submitted alongside your article.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.